Haverford Trust Co lifted its holdings in The Allstate Co. (NYSE:ALL – Free Report) by 1.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,244 shares of the insurance provider’s stock after acquiring an additional 149 shares during the period. Haverford Trust Co’s holdings in Allstate were worth $2,132,000 as of its most recent SEC filing.
Several other large investors also recently made changes to their positions in ALL. Pathway Financial Advisers LLC lifted its position in Allstate by 18,472.5% during the 3rd quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider’s stock worth $199,642,000 after acquiring an additional 1,047,019 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its position in shares of Allstate by 18.7% during the third quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider’s stock worth $569,114,000 after purchasing an additional 472,040 shares in the last quarter. AQR Capital Management LLC boosted its stake in shares of Allstate by 181.6% in the second quarter. AQR Capital Management LLC now owns 719,997 shares of the insurance provider’s stock valued at $114,955,000 after purchasing an additional 464,337 shares during the period. TimesSquare Capital Management LLC purchased a new position in Allstate in the 3rd quarter valued at about $77,819,000. Finally, Acadian Asset Management LLC grew its stake in Allstate by 3,839.0% during the 2nd quarter. Acadian Asset Management LLC now owns 416,117 shares of the insurance provider’s stock valued at $66,417,000 after purchasing an additional 405,553 shares in the last quarter. Institutional investors and hedge funds own 76.47% of the company’s stock.
Analyst Upgrades and Downgrades
ALL has been the topic of a number of research analyst reports. Barclays increased their price objective on shares of Allstate from $175.00 to $187.00 and gave the company an “underweight” rating in a research note on Thursday, October 31st. Evercore ISI increased their price target on shares of Allstate from $191.00 to $195.00 and gave the stock an “in-line” rating in a research report on Wednesday, October 9th. Keefe, Bruyette & Woods boosted their price objective on Allstate from $222.00 to $225.00 and gave the company an “outperform” rating in a report on Wednesday, November 6th. The Goldman Sachs Group upped their price objective on Allstate from $199.00 to $204.00 and gave the company a “buy” rating in a research note on Thursday, August 15th. Finally, StockNews.com lowered Allstate from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, August 21st. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $212.56.
Insider Transactions at Allstate
In other Allstate news, EVP Elizabeth Brady sold 49,481 shares of the company’s stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the completion of the sale, the executive vice president now directly owns 19,163 shares of the company’s stock, valued at approximately $3,431,901.67. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CEO Thomas J. Wilson sold 90,000 shares of the stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total value of $16,140,600.00. Following the completion of the sale, the chief executive officer now directly owns 88,552 shares of the company’s stock, valued at approximately $15,880,915.68. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Elizabeth Brady sold 49,481 shares of Allstate stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $179.09, for a total value of $8,861,552.29. Following the transaction, the executive vice president now directly owns 19,163 shares in the company, valued at approximately $3,431,901.67. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 192,530 shares of company stock valued at $34,967,665 over the last three months. Company insiders own 1.80% of the company’s stock.
Allstate Price Performance
NYSE ALL opened at $197.30 on Thursday. The firm has a market capitalization of $52.25 billion, a PE ratio of 12.78, a P/E/G ratio of 1.77 and a beta of 0.48. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.40 and a quick ratio of 0.40. The Allstate Co. has a 12 month low of $129.18 and a 12 month high of $201.00. The company’s 50 day simple moving average is $189.43 and its 200 day simple moving average is $176.25.
Allstate (NYSE:ALL – Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, topping the consensus estimate of $2.20 by $1.71. The firm had revenue of $16.63 billion for the quarter, compared to analysts’ expectations of $14.57 billion. Allstate had a net margin of 6.77% and a return on equity of 26.67%. Allstate’s revenue for the quarter was up 14.7% compared to the same quarter last year. During the same period in the previous year, the business earned $0.81 earnings per share. As a group, equities research analysts forecast that The Allstate Co. will post 16.02 EPS for the current fiscal year.
Allstate Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Recommended Stories
- Five stocks we like better than Allstate
- What Are the U.K. Market Holidays? How to Invest and Trade
- Rocket Lab is the Right Stock for the Right Time
- What Are Dividend Challengers?
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.